ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

Eudocia Q. Lee; Peixin Zhang; Patrick Y. Wen; Elizabeth R. Gerstner; David A. Reardon; Ken Aldape; John F. de Groot; Kevin S. Choe; Jeffrey J. Raizer; Lyndon J. Kim; Steven J. Chmura; H. Ian Robins; Jennifer Connelly; James Battiste; John Villano; Naveed Wagle; Ryan T. Merrell; Merideth Wendland; Minesh P. Mehta

doi:10.1093/neuonc/nov206.22

ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

Eudocia Q. Lee
, Peixin Zhang
, Patrick Y. Wen
, Elizabeth R. Gerstner
, David A. Reardon
, Ken Aldape
, John F. de Groot
, Kevin S. Choe
, Jeffrey J. Raizer
, Lyndon J. Kim
, Steven J. Chmura
, H. Ian Robins
, Jennifer Connelly
, James Battiste
, John Villano
, Naveed Wagle
, Ryan T. Merrell
, Merideth Wendland
, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	17
DOIs	https://doi.org/10.1093/neuonc/nov206.22
State	Published - Jan 11 2015

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/neuonc/nov206.22License: Unspecified

Cite this

Lee, E. Q., Zhang, P., Wen, P. Y., Gerstner, E. R., Reardon, D. A., Aldape, K., de Groot, J. F., Choe, K. S., Raizer, J. J., Kim, L. J., Chmura, S. J., Robins, H. I., Connelly, J., Battiste, J., Villano, J., Wagle, N., Merrell, R. T., Wendland, M., & Mehta, M. P. (2015). ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA. Neuro-oncology, 17. https://doi.org/10.1093/neuonc/nov206.22

Lee, EQ, Zhang, P, Wen, PY, Gerstner, ER, Reardon, DA, Aldape, K, de Groot, JF, Choe, KS, Raizer, JJ, Kim, LJ, Chmura, SJ, Robins, HI, Connelly, J, Battiste, J, Villano, J, Wagle, N, Merrell, RT, Wendland, M & Mehta, MP 2015, 'ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA', Neuro-oncology, vol. 17. https://doi.org/10.1093/neuonc/nov206.22

@article{c84c332b0dd54708bbbea459ec4e0cd3,

title = "ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA",

author = "Lee, \{Eudocia Q.\} and Peixin Zhang and Wen, \{Patrick Y.\} and Gerstner, \{Elizabeth R.\} and Reardon, \{David A.\} and Ken Aldape and \{de Groot\}, \{John F.\} and Choe, \{Kevin S.\} and Raizer, \{Jeffrey J.\} and Kim, \{Lyndon J.\} and Chmura, \{Steven J.\} and Robins, \{H. Ian\} and Jennifer Connelly and James Battiste and John Villano and Naveed Wagle and Merrell, \{Ryan T.\} and Merideth Wendland and Mehta, \{Minesh P.\}",

year = "2015",

month = jan,

day = "11",

doi = "10.1093/neuonc/nov206.22",

language = "American English",

volume = "17",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

AU - Lee, Eudocia Q.

AU - Zhang, Peixin

AU - Wen, Patrick Y.

AU - Gerstner, Elizabeth R.

AU - Reardon, David A.

AU - Aldape, Ken

AU - de Groot, John F.

AU - Choe, Kevin S.

AU - Raizer, Jeffrey J.

AU - Kim, Lyndon J.

AU - Chmura, Steven J.

AU - Robins, H. Ian

AU - Connelly, Jennifer

AU - Battiste, James

AU - Villano, John

AU - Wagle, Naveed

AU - Merrell, Ryan T.

AU - Wendland, Merideth

AU - Mehta, Minesh P.

PY - 2015/1/11

Y1 - 2015/1/11

UR - http://neuro-oncology.oxfordjournals.org/content/17/suppl_5/v6.2.full.pdf

U2 - 10.1093/neuonc/nov206.22

DO - 10.1093/neuonc/nov206.22

M3 - Article

VL - 17

JO - Neuro-oncology

JF - Neuro-oncology

ER -

ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

Disciplines

Access to Document

Other files and links

Cite this